Higher inflammation prior to chemotherapy can predict frailty after chemotherapy ends, the researchers report.
Characterized by weakness, fatigue, weight loss, and slow walking speed, frailty is associated with cancer and its treatments. Scientists are studying the factors that lead to frailty and how to prevent it because it can impact quality of life and how a person of any age endures disease.
“Our findings confirm that oncologists should consider inflammation and frailty in their patients, and perhaps personalize treatment, especially in older adults, to avoid undue risks of chemotherapy toxicity,” says first author Nikesha Gilmore, research assistant professor of surgery at the University of Rochester Medical Center, who conducts studies for Wilmot’s Cancer Prevention and Control program.
Researchers to test a promising treatment for high-risk COVID-19 outpatients
The nation has been coping with the pandemic for more than a year, and in this time, researchers have learned a great deal about how to treat COVID-19. Yet they have also been faced with what they still must learn, including how to reach the individuals who have been most dramatically impacted by the disease and who could benefit the most from new treatments.
A new $8.7 million grant from the National Institutes of Health (NIH) will fuel these efforts for the next two years. Adit Ginde, MD, MPH, professor of emergency medicine at CU School of Medicine and UCHealth emergency physician is leading a team of researchers from the Colorado Clinical and Translational Sciences Institute at the University of Colorado Anschutz Medical Campus to test the real-world effectiveness of a promising treatment for high-risk COVID-19 outpatients.
Aisha Langford | The Communication Initiative Network comminit.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from comminit.com Daily Mail and Mail on Sunday newspapers.
E-Mail
The West Virginia Clinical and Translational Science Institute (WVCTSI) will host a special virtual event titled HIV in Rural America on March 18. During this event, researchers, state, and national health experts will discuss research presented in The Lancet s recent issue: HIV in the United States.
The event will kick off at 11:30 a.m. with brief research presentations from authors published in The Lancet issue with Sally Hodder, MD, WVCTSI director and associate vice president for clinical and translational research at WVU moderating. Presenters and topics include:
Patrick Sullivan, DVM, PhD (Emory University). Epidemiology of HIV in the USA: Epidemic Burden, Inequities, Context, and Responses
$1 million gift from Manizheh Yomtoubian establishes faculty chair at UCLA Engineering ucla.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ucla.edu Daily Mail and Mail on Sunday newspapers.